ConductScience.org, home

Paper31064751

Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms.

Schischlik F and 23 others. Blood, 2019. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms. Papers, record 31064751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31064751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms.
PubMed
Journal
Blood
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2025-05-30
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schischlik FFiorellahttps://orcid.org/0000-0003-4299-7657
2Jäger RRoland
3Rosebrock FFelix
4Hug EEva
5Schuster MMichaelhttps://orcid.org/0000-0003-2975-8969
6Holly RRaimund
7Fuchs EElisabeth
8Milosevic Feenstra JDJelena Dhttps://orcid.org/0000-0001-7420-3298
9Bogner EEdith
10Gisslinger BBettina
11Schalling MMartin
12Rumi EElisahttps://orcid.org/0000-0002-7572-9504
13Pietra DDaniela
14Fischer GGottfried
15Faé IIngridhttps://orcid.org/0000-0002-7698-5526
16Vulliard LLoanhttps://orcid.org/0000-0002-2260-4935
17Menche JJörghttps://orcid.org/0000-0002-1583-6404
18Haferlach TTorsten
19Meggendorfer MManja
20Stengel AAnna

Source PubMed

See all 24 authorsDownload CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Myeloproliferative DisordersMajor topic
Aged
Calreticulin
Female
Humans
Immunotherapy
Male
Middle Aged
Mutation
Receptors, Thrombopoietin
Sequence Analysis, RNA
Transcriptome

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P 29018Austrian Science Fund FWFAustriaPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in31296544Finding Neo (antigens, that is).https://conductscience.org/library/papers/31296544

Source PubMed

Download CSV of comments and corrections

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129279605Cancer transcriptome profiling at the juncture of clinical translation.Nat Rev Genet2018https://conductscience.org/library/papers/29279605PubMed
227622333Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.Cancer Cell2016https://conductscience.org/library/papers/27622333PubMed
323259685HLA typing from RNA-Seq sequence reads.Genome Med2012https://conductscience.org/library/papers/23259685PubMed
422588898Chimeras taking shape: potential functions of proteins encoded by chimeric RNA transcripts.Genome Res2012https://conductscience.org/library/papers/22588898PubMed
511687624Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11687624PubMed
629132146Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.Nature2017https://conductscience.org/library/papers/29132146PubMed
728678784Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.Nature2017https://conductscience.org/library/papers/28678784PubMed
826565915Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.Cell Rep2015https://conductscience.org/library/papers/26565915PubMed
926928227Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.Nat Genet2016https://conductscience.org/library/papers/26928227PubMed
1027560107The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms.Leukemia2016https://conductscience.org/library/papers/27560107PubMed
1120952405COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.Nucleic Acids Res2011https://conductscience.org/library/papers/20952405PubMed
1227282250RNA splicing factors as oncoproteins and tumour suppressors.Nat Rev Cancer2016https://conductscience.org/library/papers/27282250PubMed
1325183062Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer.BMC Syst Biol2014https://conductscience.org/library/papers/25183062PubMed
1426842708Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.Nat Commun2016https://conductscience.org/library/papers/26842708PubMed
1517406393Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.Nat Protoc2006https://conductscience.org/library/papers/17406393PubMed
1628678778An immunogenic personal neoantigen vaccine for patients with melanoma.Nature2017https://conductscience.org/library/papers/28678778PubMed
1720644199The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.Genome Res2010https://conductscience.org/library/papers/20644199PubMed
1821995386Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.N Engl J Med2011https://conductscience.org/library/papers/21995386PubMed
1916247014The response of autologous T cells to a human melanoma is dominated by mutated neoantigens.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/16247014PubMed
2030078747Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.Cancer Cell2018https://conductscience.org/library/papers/30078747PubMed

See all 40 referencesDownload CSV of references

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
42860554Haematopoietic Cells Deficient for Calreticulin or Expressing Its Oncogenic Variants Maintain Functional Antigen Presentation.J Cell Mol Med2026https://conductscience.org/library/papers/42860554PubMed
42806564The Impact of SF3B1 Mutations on the Tumor Microenvironment and Response to Immunotherapy.Cancer Med2026https://conductscience.org/library/papers/42806564PubMed
41959062Platelets Outperform Leukocytes in Transcriptomic Liquid Biopsy Profiling of Myeloproliferative Neoplasms.bioRxiv2026https://conductscience.org/library/papers/41959062PubMed
41798678Mutant calreticulin-directed immunotherapies in myeloproliferative neoplasms.Blood Neoplasia2026https://conductscience.org/library/papers/41798678PubMed
41481381A stem and progenitor cell-derived gene expression signature is prognostic for survival in myelofibrosis.Blood2026https://conductscience.org/library/papers/41481381PubMed
41316436Alternative splicing: from tumorigenesis to neoantigen-mediated cancer immunotherapy.Biomark Res2025https://conductscience.org/library/papers/41316436PubMed
41011502Genomic and Transcriptomic Profiling of a Highly Virulent Plesiomonas shigelloides Strain: Insights into Pathogenicity and Host Immune Response.Microorganisms2025https://conductscience.org/library/papers/41011502PubMed
40373279Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24.Blood2025https://conductscience.org/library/papers/40373279PubMed
40264064Potential application of the bulk RNA sequencing in routine MPN clinics.BMC Cancer2025https://conductscience.org/library/papers/40264064PubMed
39682299Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations.Cancers (Basel)2024https://conductscience.org/library/papers/39682299PubMed
39351227Differential modulation of mutant CALR and JAK2 V617F-driven oncogenesis by HLA genotype in myeloproliferative neoplasms.Front Immunol2024https://conductscience.org/library/papers/39351227PubMed
38760666Biological relevance of alternative splicing in hematologic malignancies.Mol Med2024https://conductscience.org/library/papers/38760666PubMed
38731892Tumor Antigens beyond the Human Exome.Int J Mol Sci2024https://conductscience.org/library/papers/38731892PubMed
38652240Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis.Ann Hematol2024https://conductscience.org/library/papers/38652240PubMed
37915324Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?Front Med (Lausanne)2023https://conductscience.org/library/papers/37915324PubMed
37666991Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.Nat Genet2023https://conductscience.org/library/papers/37666991PubMed
37662956
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.
Front Immunol2023https://conductscience.org/library/papers/37662956PubMed
37284191Mutations, inflammation and phenotype of myeloproliferative neoplasms.Front Oncol2023https://conductscience.org/library/papers/37284191PubMed
36831689Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them?Cancers (Basel)2023https://conductscience.org/library/papers/36831689PubMed
36814396Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.Am J Hematol2023https://conductscience.org/library/papers/36814396PubMed

See all 58 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
MPL4352PubTator's text mininghttps://conductscience.org/library/genes/4352NCBI Gene
SF3B123451PubTator's text mininghttps://conductscience.org/library/genes/23451NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31064751

GET https://conductscience.org/api/papers/v1/31064751/authors?page=2